Pages that link to "Q28188643"
Jump to navigation
Jump to search
The following pages link to Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta (Q28188643):
Displaying 50 items.
- High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse (Q21136177) (← links)
- Evolutionary origins of insulin resistance: a behavioral switch hypothesis (Q21283908) (← links)
- Inflammation and insulin resistance (Q22241893) (← links)
- Obesity, Inflammation, and Insulin Resistance (Q22250939) (← links)
- Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy (Q22299231) (← links)
- Is NF-kappaB a culprit in type 2 diabetes? (Q23912824) (← links)
- Insulin signalling and the regulation of glucose and lipid metabolism (Q24292020) (← links)
- Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101) (Q24303870) (← links)
- S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2 (Q24309036) (← links)
- Inflammation, stress, and diabetes (Q24523336) (← links)
- Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse (Q24564225) (← links)
- B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies (Q24598772) (← links)
- "Control" laboratory rodents are metabolically morbid: why it matters (Q24599731) (← links)
- Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism (Q24608263) (← links)
- Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance (Q24617743) (← links)
- The ancient drug salicylate directly activates AMP-activated protein kinase (Q24630758) (← links)
- Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction (Q24632414) (← links)
- Transcription factor 7-like 2 polymorphism and colon cancer (Q24654061) (← links)
- The protein kinase IKKepsilon regulates energy balance in obese mice (Q24658201) (← links)
- An inflammatory cascade leading to hyperresistinemia in humans (Q24796813) (← links)
- Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes (Q24811670) (← links)
- Prevalence, predisposition and prevention of type II diabetes (Q24815863) (← links)
- Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis (Q26746659) (← links)
- Metabolic Inflammation-Differential Modulation by Dietary Constituents (Q26748868) (← links)
- Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches (Q26752576) (← links)
- Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders (Q26752618) (← links)
- Obesity and cancer, a case for insulin signaling (Q26771452) (← links)
- Type-2 diabetes: Current understanding and future perspectives (Q26801324) (← links)
- Insulin receptor signaling in normal and insulin-resistant states (Q26823171) (← links)
- Nutritional modulation of insulin resistance (Q26824738) (← links)
- Reactive oxygen species in health and disease (Q26851203) (← links)
- Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective (Q26852364) (← links)
- Targeting inflammation in diabetes: Newer therapeutic options (Q26852726) (← links)
- Something old, something new and something very old: drugs for treating type 2 diabetes (Q26865663) (← links)
- Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets (Q26866480) (← links)
- IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression (Q27025620) (← links)
- The immune system as a sensor of the metabolic state (Q27026072) (← links)
- Regulation of stem cell differentiation in adipose tissue by chronic inflammation (Q27028193) (← links)
- Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance (Q27347641) (← links)
- STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER? (Q27478329) (← links)
- Molecular mechanisms of insulin resistance in chronic hepatitis C (Q27489665) (← links)
- Implication of inflammatory signaling pathways in obesity-induced insulin resistance (Q27500365) (← links)
- Inflammation and metabolic disorders (Q27860923) (← links)
- (Q28165179) (redirect page) (← links)
- Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance (Q28167026) (← links)
- Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in growth hormone treated animals (Q28176156) (← links)
- Opportunities for the treatment of inflammation in cardiovascular disease (Q28192292) (← links)
- Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes (Q28193039) (← links)
- Cyclooxygenase-2 (PTGS2) inhibitors augment the rate of hexose transport in L6 myotubes in an insulin- and AMPKalpha-independent manner (Q28194739) (← links)
- Effect of castration on acetyl salicylic acid metabolism in rabbits (Q28195396) (← links)